quinazolines has been researched along with azomycin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meingassner, JG; Mieth, H; Nesvadba, H | 1 |
| Afonso, LC; Bahia, MT; Chiari, E; de Lana, M; Guedes, PM; Machado-Coelho, GL; Tafuri, WL; Urbina, JA; Veloso, VM | 1 |
| Binns, D; Cullinane, C; Hicks, RJ; McArthur, GA; Roselt, P; Solomon, B; Weibe, LI | 1 |
| Bloomer, WD; Papadopoulou, MV | 1 |
| Baker, LC; Boult, JK; Burrell, JS; Halliday, J; Jamin, Y; Robinson, SP; Ryan, AJ; Walker-Samuel, S; Waterton, JC | 1 |
| Hussar, DA | 1 |
| Cheng, W; Hu, Y; Tian, X; Wang, S; Yang, Z | 1 |
7 other study(ies) available for quinazolines and azomycin
| Article | Year |
|---|---|
New chemotherapeutic nitroheterocycles active against 5-nitroimidazole-resistant strains of trichomonads.
Topics: Animals; Antitrichomonal Agents; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Female; Mice; Nitroimidazoles; Quinazolines; Rats; Trichomonas; Trichomonas vaginalis; Trichomonas Vaginitis | 1981 |
Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.
Topics: Animals; Chagas Disease; Dogs; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Monocytes; Nifurtimox; Nitroimidazoles; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2004 |
Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorine Radioisotopes; Gefitinib; Humans; Hypoxia; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nitroimidazoles; Oxidation-Reduction; Oxygen; Positron-Emission Tomography; Quinazolines; Tissue Distribution | 2005 |
Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cricetinae; Cricetulus; Drug Synergism; Gamma Rays; Humans; Molecular Structure; Naphthyridines; Nitroimidazoles; Quinazolines; Radiation-Sensitizing Agents | 2009 |
Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas.
Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Biomarkers, Tumor; Contrast Media; Dextrans; Fluorescent Dyes; Glioma; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Nitroimidazoles; Quinazolines; Radiation-Sensitizing Agents; Rats; Rats, Nude; Tumor Cells, Cultured | 2012 |
New Drugs 2018, part 3.
Topics: Acetates; Boronic Acids; Drug Approval; Drug Combinations; Fluoroquinolones; Humans; Meropenem; Metronidazole; Nitroimidazoles; Parathyroid Hormone-Related Protein; Peptides; Prostaglandins F, Synthetic; Quinazolines; Thienamycins; United States; United States Food and Drug Administration | 2018 |
Design, synthesis, and biological study of 4-[(2-nitroimidazole-1
Topics: A549 Cells; Aniline Compounds; Antineoplastic Agents; Cell Hypoxia; ErbB Receptors; HT29 Cells; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Neoplasms; Nitroimidazoles; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship | 2019 |